Gallick, Gary E.

Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

Talamonti, M. S., Roh, M. S., Curley, S. A., & Gallick, G. E. (1993) · Journal of Clinical Investigation

Protein Kinase Regulation and GTPase SignalingCancer Mechanisms and Therapy

Cited by 399

Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

Mao, M., Tian, F., Mariadason, J. M., Tsao, C. C., Lemos, R., Dayyani, F., Gopal, Y. N. V., Jiang, Z.-Q., Wistuba, I. I., Tang, X. M., et al. (2013) · Clinical Cancer Research

Colorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways

Cited by 290

Activation of Src kinase in primary colorectal carcinoma: An indicator of poor clinical prognosis

Allgayer, H., Boyd, D. D., Heiss, M. M., Abdalla, E. K., Curley, S. A., & Gallick, G. E. (2002) · Cancer

Cancer Mechanisms and TherapyProtein Kinase Regulation and GTPase Signaling

Cited by 251

Src activation by β-adrenoreceptors is a key switch for tumour metastasis

Armaiz-Pena, G. N., Allen, J. K., Cruz, A., Stone, R. L., Nick, A. M., Lin, Y. G., Han, L. Y., Mangala, L. S., Villares, G. J., Vivas-Mejia, P., et al. (2013) · Nature Communications

Cancer, Stress, Anesthesia, and Immune ResponseProtein Kinase Regulation and GTPase Signaling

Cited by 212

Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players

Kim, M. P., & Gallick, G. E. (2008) · Clinical Cancer Research

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 177

Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress

Kopetz, S., Lesslie, D. P., Dallas, N. A., Park, S. I., Johnson, M., Parikh, N. U., Kim, M. P., Abbruzzese, J. L., Ellis, L. M., Chandra, J., et al. (2009) · Cancer Research

Colorectal Cancer Treatments and StudiesCancer Mechanisms and Therapy

Cited by 160

Src continues aging: current and future clinical directions

Kopetz, S., Shah, A. N., & Gallick, G. E. (2007) · Clinical Cancer Research

Cancer Mechanisms and TherapyProtein Kinase Regulation and GTPase Signaling

Cited by 111

Site-Specific Differences in pp60c-src Activity in Human Colorectal Metastases

Termuhlen, P. M., Curley, S. A., Talamonti, M. S., Saboorian, M. H., & Gallick, G. E. (1993) · Journal of Surgical Research

Protein Kinase Regulation and GTPase SignalingCancer Mechanisms and Therapy

Cited by 108

Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer

Parseghian, C. M., Parikh, N. U., Wu, J. Y., Jiang, Z.-Q., Henderson, L., Tian, F., Pastor, B., Ychou, M., Raghav, K., Dasari, A., et al. (2017) · Clinical Cancer Research

Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations

Cited by 67

Unravelling the pivotal role of Alix in MVB sorting and silencing of the activated EGFR

Sun, S., Zhou, X., Zhang, W., Gallick, G. E., & Kuang, J. (2015) · Biochemical Journal

Cellular transport and secretionUbiquitin and proteasome pathways

Cited by 37

Phase IB study of the Src inhibitor dasatinib with FOLFOX and cetuximab in metastatic colorectal cancer.

Lieu, C. H., Wolff, R. A., Eng, C., Overman, M. J., Henry, L., Coulson, R., Garrett, C. R., Abbruzzese, J. L., Gallick, G. E., & Kopetz, S. (2010) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 10